Interferon-γ: Biology and role in pathogenesis

Advances in Immunology

Volumn 62, Issue , 1996, Pages 61-130

  Billiau, Alfons ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOKINE; MACROPHAGE ACTIVATING FACTOR; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTHRITIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL PROTECTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; INFLAMMATION; INSULITIS; INTERFERON INDUCTION; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIOSIS; NATURAL KILLER CELL; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; T LYMPHOCYTE; VIRUS INFECTION; VIRUS RESISTANCE;

EID: 0029994319     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (375)

1. Wheelock, E. F. (1965). Interferon-like virus inhibitor induced in human leukocytes by phytohemagglutinin. Science 141, 30-311.
2. Youngner, J., and Salvin, S. B. (1973). Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed type hypersensitivity. J. Immunol. 111, 1914-1
3. Falcoff, R. (1972). Some properties of virus- and immune-induced human lymphocyte interferons. J. Gen. Virol. 16, 251-253.
4. Stewart, W. E. I., et al. (1980). Interferon nomenclature. Nature 286, 110.
5. Nathan, C., Murray, H. W., Wiebe, M. E., and Rubin, B. Y. (1983). Identification of interferon-y as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158, 670-681.
6. 5a. Bloom, B. R., and Bennett, B. (1966). Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153, 80-82.
7. Steeg, P., Moore, R. N., Johnson, H. M., and Oppenheim, J. J. (1982). Regulation of murine macrophage la antigen expression by a lymphokine with immune interferon activity. J. Exp. Med. 156, 1780-1793.
8. Weinberg, J. B., Chapman, H. A., and Hibbs, J. B. (1978). Characterization of the effects of endotoxin on macrophage tumor cell killing. J. Immunol. 121, 72-80.
9. Farrar, M. A., and Schreiber, R. D. (1993). The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11, 571-611.
10. Ijzermans, J., and Marquet, R. L. (1989). Interferon-gamma: A review. Immunobiology 179, 456-473.
11. Ealick, S. E., Cook, W. J., Vijay Kumar, S., Carson, M., Nagabhushan, T. L., Trotta, P. P., and Bugg, C. E. (1991). Three-dimensional structure of recombinant human interferon-y. Science 252, 698-702.
12. Walter, M., Windsor, W. T., Nagabushan, T. L., Lundell, D. J., Lunn, C. A., Zauodny, P. J., and Narula, S. K. (1995). Crystal structure of a complex between interferon-y and its soluble high-affinity receptor. Nature 376, 230-235.
13. Griggs, N. D., Jarpe, M. A., Pace, J. L., Russell, S. W., and Johnson, H. M. (1992). The N-terminus and C-terminus of IFN-gamma are binding domains for cloned soluble IFN-gamma recepto r. J. Immunol. 149, 517-520.
14. Van Volkenburg, M. A., Griggs, N. D., Jarpe, M. A., Pace, J. L., Russell, S. W., and Johnson, H. M. (1993). Binding site on the murine IFN-gamma receptor for IFNgamma has been identified using the synthetic peptide approach. J. Immunol. 151, 6206-6213.
15. Sareneva, T., Pirhonen, J., Cantell, K., Kalkkinen, N., and Julkunen, I. (1994). Role of N-glycosylation in the synthesis, dimerization and secretion of human interferon-gamma. Biochem. J. 303, 831-840.
16. Schreiber, R. D., Hicks, L. J., Celada, A., Buchmeier, N. A., and Gray, P. W. (1985). Monoclonal antibodies to murine y-interferon which differentially modulate macrophage activation and antiviral activity. J. Immunol. 134, 1609-1618.
17. Kwok, A. Y. C, Zu, X., Yang, C., Alfa, M. J., and Jay, F. T. (1993). Human interferon-γ has three domains associated with its antiviral function: A neutralizing epitope typing scheme for human interferon-y. Immunology 78, 131-137.
18. Fong, T. A., and Mosmann, T. R. (1990). Alloreactive murine CD8 + T cell clones secrete the Thl pattern of cytokines. J. Immunol. 144, 1744-1752.
19. Alzona, M., Jäck, H.-M., Fisher, R. I., and Ellis, T. M. (1994). CD30 defines a subset of activated human T cells that produce IFN-y and IL-5 and exhibit enhanced B cell helper activity. J. Immunol 153, 2861-2867.
20. Fultz, M. J., Barber, S. A., Dieffenbach, C. W., and Vogel, S. N. (1995). Induction of IFN-gamma in macrophages by lipopolysaccharide. Int. Immunol. 5, 1383-1392.
21. Yoshihara, R., Shiozawa, S., Fujita, T., and Chihara, K. (1993). Gamma interferon is produced by human natural killer cells but not T cells during Staphylococcus aureus stimulation. Infect. Immun. 61, 3117-3122.
22. Dunn, P., and North, R. J. (1991). Early gamma interferon production by natural killer cells is important in defense against murine listeriosis. Infect. Immun. 59, 2892-2900.
23. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178, 567-577.
24. Wherry, J. C, Schreiber, R. D., and Unanue, E. R. (1991). Regulation of gamma interferon production by natural killer cells in scid mice: Roles of tumor necrosis factor and bacterial stimuli. Infect. Immun. 59, 1709-1715.
25. Bancroft, G. J., Sheehan, K. C. F., Schreiber, R. D., and Unanue, E. R. (1989). Tumor necrosis factor is involved in the T cell independent pathway of macrophage activation in scid mice. J. Immunol. 143, 127-130.
26. Rothe, J., Lesslauer, W., Lotscher, H., Lang, Y., Koebel, P., Käntgen, F., Althage, A., Zinkernagel, R., Steinmetz, M., and Bluethmann, H. (1993). Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798-802.
27. Chan, S. H., Kobayashi, M., Santoli, D., Perussia, B., and Trinchieri, G. (1992). Mechanisms of IFN-y induction by natural killer cell stimulatory factor (NKSF/IL-1 2). J. Immunol. 148, 92-98.
28. Yaegashi, Y., Nielsen, P., Sing, A., Galanos, C., and Freudenberg, M. A. (1995). Interferon β, a cofactor in the interferon gamma production induced by gram-negative bacteria in mice. J. Exp. Med. 181, 953-960.
29. Heinzel, F. P., Rerko, R. M., Ling, P., Hakimi, J., and Schoenhaut, D. S. (1994). Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect. Immun. 62, 4244-4249.
30. Heremans, H., Dillen, C., Van Damme, J., and Billiau, A. (1994). Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice. Eur. J. Immunol. 24, 1155-1160.
31. D'Orazio, J. A., Burke, G. W., and Stein-Streilein, J. (1995). Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-gamma but requires T lymphocytes to augment NK cytotoxicity. J. Immunol. 154, 1014-1023.
32. Flesch, I. E. A., Hess, J. H., Huang, S., Aguet, M., Rothe, J., Bluethmann, H., and Kaufmann, S. H. E. (1995). Early interleukin-12 production by macrophages in response to mycobacterial infections depends on interferon y and tumor necrosis factor. J. Exp. Med. 181, 16
33. Gazzinelli, R. T., Wysocka, M., Hayashi, S., Denkers, E. Y., Hieny, S., Caspar, P., Trinchieri, G., and Sher, A. (1994). Parasite-induced IL-12 stimulates early IFNgamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153, 2533-2543.
34. Morris, A. G., Lin, Y., and Askonas, B. A. (1982). Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell. Nature 295, 150-152.
35. Wingren, A. G., Dahlenborg, K., Bjorklund, M., Hedlund, G., Kalland, T., Sjogren, H. O., Ljungdahl, A., Olsson, T., Ekre, H. P., and Sanson, D. (1993). Monocyteregulated IFN-gamma production in human T cells involves CD2 signaling. J. Immunol. 151, 1328-1336.
36. Yang, X., and HayGlass, K. T. (1993). IFN-gamma, but not IL-4, synthesis by antigen-primed murine T cells is IL-2 dependent: Differential requirements in de novo and established responses. J. Immunol. 150, 4354-4363.
37. Seder, R. A., Gazzinelli, R., Sher, A., and Paul, W. E. (1993). Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90, 10188-10192.
38. + T cells. J. Immunol. 154, 9-16.
39. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150, 5321-5329.
40. Ye, J., Ghosh, P., Cippitelli, M., Subleski, J., Hardy, K. J., Ortaldo, J. R., and Young, H. A. (1994). Characterization of a silencer regulatory element in the human interferon-gamma promoter. J. Biol. Chem. 269, 25728-25734.
41. Finbloom, D. S.,Wahl, L. M., and Winestock, K. D. (1991). The receptor for interferon-'y on human peripheral blood monocytes consists of multiple distinct units. J. Biol. Chem. 266, 22545-22548.
42. Rashidbaigi, A., Langer, J. A., Jung, V., Jones, C., Morse, H. G., Tischfield, J. A., Trill, J. J., Kung, H., and Pestka, S. (1986). The gene for the human immune interferon receptor is located on chromosome 6. Proc. Natl. Acad. Sci. USA 83, 384-388.
43. Hemmi, S., Peghini, P., Metzler, M., Merlin, G., Dembic, Z., and Aguet, M. (1989). Cloning of murine interferon y receptor cDNA: Expression in human cells mediates high-affinity binding but is not sufficient to confer sensitivity to murine interferon y. Proc. Natl. Acad. Sci. USA 86, 9901-9905.
44. Aguet, M., Dembic, Z., and Merlin, G. (1988). Molecular cloning expression of the human interferon-gamma receptor. Cell 55, 273-280.
45. Hibino, Y., Kumar, C. S., Mariano, T. M., and Pestka, S. (1992). Chimeric interferon-y receptors demonstrate that an accessory factor required for activity interacts with the extracellular domain. J. Biol. Chem. 267, 3741-3749.
46. Jung, V., Jones, C., Kumar, C., Stefanos, S., O'Connell, S., and Pestka, S. (1990). Expression and reconstitution of a biologically active human interferon-γ receptor in hamster cells. J. Biol. Chem. 265, 1827-1830.
47. Hibino, Y., Mariano, T. M., Kumar, C. S., Kozak, C. A., and Pestka, S. (1991). Expression and reconstitution of a biologically active mouse interferon-γ receptor in hamster cells. J. Biol. Chem. 266
48. Soh, J., Donnelly, R. J., Kotenko, S., Mariano, T. M., Cook, J. R., Wang, N., Emanuel, S., Schwartz, B., Mild, T., and Pestka, S. (1994). Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor. Cell 76, 793-802.
49. Hemmi, S., Böhni, R., Stark, G., Di Marco, F., and Aguet, M. (1994). A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells. Cell 76, 803-810.
50. Soh, J., Donnelly, R., Mariano, T., Cook, J., Schwartz, B., and Pestka, S. (1993). Identification of a yeast artificial chromosome clone encoding an accessor factor for the human interferon gamma receptor: Evidence for multiple accessor factors. Proc. Natl. Acad. Sci. USA 90, 8737-8741.
51. Greenlund, A. C, Schreiber, R. D., Goeddel, D. V., and Pennica, D. (1993). Interferon-gamma induces receptor dimerization in solution and on cells. J. Biol. Chem. 268, 18103-18110.
52. Axelrod, A., Gibbs, V. C., and Goeddel, D. V. (1994). The interferon-gamma receptor extracellular domain. Non-identical requirements for ligand binding and signaling. J. Biol. Chem. 269, 15
53. Szente, B. E., and Johnson, H. M. (1994). Binding of IFNgamma and its C-terminal peptide to a cytoplasmic domain of its receptor that is essential for function. Biochem. Biophys. Res. Commun. 201, 215-221.
54. Finbioom, D. S., and Wahl, L. M. (1989). Characterization of a novel low affinity receptor for IFN--y on adherent human monocytes by radioligand binding studies and chemical cross-linking. J. Immunol. 142, 2314-2320.
55. Krakauer, T., and Oppenheim, J. J. (1993). IL-1 and tumor necrosis factor-α each up-regulate both the expression of IFN-γ receptors and enhance IFN-γ-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). J. Immunol. 150, 1205-121
56. Raitano, A. B., and Korc, M. (1990). Tumor necrosis factor up-regulates γ-interferon binding in a human carcinoma cell. J. Biol. Chem. 265, 10466-10472.
57. Sanceau, J., Merlin, G., and Wietzerbin, J. (1992). Tumor necrosis factor and IL-6 upregulate IFN-γ receptor gene expression in human monocytic THP-1 cells by transcriptional and post-transcriptional mechanisms. J. Immunol. 149, 1671-1675.
58. Chen, H.-L., Kamath, R., Pace, J. L., Russell, S. W., and Hunt, J. S. (1994). Gestation-related expression of the interferon-gamma receptor gene in mouse uterine and embryonic hematopoietic cells. J. Leukocyte Biol. 55, 617-625.
59. Taniguchi, T. (1995). Cytokine signalling through nonreceptor protein tyrosine kinases. Science 268, 255.
60. Larner, A. C., David, M., Feldman, G. M., Igarashi, K., Hackett, R. H., Webb, D. S. A., Sweitzer, S. M., Petricoin, E. F., III, and Finbioom, D. S. (1993). Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science 261, 1730-1733.
61. Ruff-Jamison, S., Chen, K., and Cohen, S. (1993). Induction by EGF and interferon-gamma of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science 261, 1733-1736.
62. Sadowski, H. B., Shuai, K., Darnell, J. E., Jr., and Gilman, M. Z. (1993). A common nuclear signal transduction pathway activated by growth factor and cytokine receptors, Science 261, 1739-1744.
63. Silvennoinen, O., Schindler, C., Schlessinger, J., and Levy, E. (1993). Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. Science 261, 1736-1739.
64. Watling, D., Guschin, D., Müller, M., Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., Rogers, N. C, Schindler, C., Stark, G. R., Ihle, J. N., and Kerr, I. M. (1993). Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature 366, 166-170.
65. Igarashi, K., Garotta, G., Ozmen, L., Ziemiecki, A., Wilks, A. F., Harpur, A. G., Larner, A. C, and Finbioom, D. S. (1994). Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jakl and Jak2, with its receptor. J. Biol. Chem. 269, 14333-14336.
66. Greenlund, A. C., Farrar, M. A., Viviano, B. L., and Schreiber, R. D. (1994). Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 13, 1591-1600.
67. Heim, M. H., Kerr, I. M. Stark, G. R., and Darnell, J. E., Jr. (1995). Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science 267, 1347-1349.
68. Stark, G., and Kerr, I. M. (1992). Interferon-dependent signaling pathways: DNA elements transcription factors, mutations, and effects of viral proteins. J. Interferon Res. 12, 147-151.
69. Schindler, C., Shuai, K., Precioso, V. R., and Darnell, J. E. J. (1992). Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257, 809-813.
70. Shuai, K., Schindler, C., Precioso, V. R., and Darnell, J. E. J. (1992). Activation of transcription by IFN-y: Tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258, 1808-1812.
71. Fujita, T., Sakakibara, J., Sudo, Y., Miyamoto, M., Kimura, Y., and Taniguchi, T. (1988). Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-β gene regulatory elements. EMBO J. 7, 3397-3405.
72. Harada, H., Takahashi, E.-L, Itoh, S., Harada, K., Hori, T.-A., and Taniguchi, T. (1994). Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: Implications for a gene network in the interferon system. Mol. Cell. Biol. 14, 1500-1509.
73. Pearse, R. N., Feinman, R., and Ravetch, J. V. (1991). Characterization of the promotor of the human gene encoding the high-affinity IgG receptor: Transcriptional induction by gamma-interferon is mediated through common DNA response elements. Proc. Natl. Acad. Sci. USA 88, 11305-11309.
74. Wong, P., Severns, C. W., Guyer, N. B., and Wright, T. M. (1994). A unique palindromic element mediates gamma interferon induction of mig gene expression. Mol. Cell. Biol. 14, 914-922.
75. Fan, X.-D., Golberg, M., and Bloom, B. R. (1988). Interferon-y-induced transcriptional activation is mediated by protein kinase. Proc. Natl. Acad. Sci. USA 85, 5122-5125.
76. Politis, A. D., Sivo, J., and Vogel, S. N. (1993) Multiple pathways of interferon-induced gene expression in murine macrophages. J. Leukocyte Biol. 53, 583-590.
77. Koide, Y., Ina, Y., Nezu, N., and Yoshida, T. O. (1988). Calcium influx and the Ca2+calmodulin complex are involved in interferon-y-induced expression of HLA class II molecules on HL-60 cells. Proc. Natl. Acad. Sci. USA 85, 3120-3124.
78. Ryu, K., Koide, Y., Yamashita, Y., and Yoshida, T. O. (1993). Inhibition of tyrosine phosphorylation prevents IFN-γ-induced HLA-DR molecule expression. J. Immunol. 150, 1253-1262.
79. Anderson, P., Yip, Y. K., and Vilcek, J. (1983). Human interferon-y is internalized and degraded by cultured fibroblasts. J. Biol. Chem. 258, 6497-6502.
80. Wietzerbin, J., Gaudelet, C. Aguet, M., and Falcoff, E. (1986). Binding and cross-linking of recombinant mouse interferon-y to receptors in mouse leukemic L1210 cells; Interferon-y internalization nd receptor down-regulation. J. Immunol. 136,2451-2455.
81. Bradley, J. R., Johnson, D. R., and Pober, J. S. (1993). Four different classes of inhibitors of receptor-mediated endocytosis decrease tumor necrosis factor-induced gene expression in human endothelial cells. J. Immunol. 150, 5544-5555.
82. Celada, A., and Schreiber, R. D. (1987). Internalization and degradation of receptor-bound interferon-y by murine macrophages. Demonstration of receptor recycling. J. Immunol. 139, 147-
83. Smith, M. R., Muegge, K., Keller, J. R., Kung, H.-F., Young, H. A., and Durum, S. K. (1990). Direct evidence for an intracellular role for IFN-γ. J. Immunol. 144,1777-1782.
84. Sanceau, J., Sondermeyer, P., Béranger, F., Falcoff, R., and Vaquero, C. (1987). Intracellular human gamma-interferon triggers an antiviral state in transformed murine L cells. Proc. Natl. Acad. Sci. USA 84, 2906-2910.
85. Fidler, I. J., Fogler, W. E., Kleinermann, E. S., and Saiki, I. (1985). Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes. J. Immunol. 135, 4289-4296.
86. Bader, T., and Wietzerbin, J. (1994). Nuclear accumulation of interferon gamma. Proc. Natl. Acad. Sci. USA 91, 11831-11835.
87. Zu, X., and Jay, F. T. (1991). The E1 functional epitope of the human interferon gamma is a nuclear targeting signal-like element. J. Biol. Chem. 266, 6023-6026.
88. Slodowski, O., Bohm, J., Schone, B., and Otto, B. (1991). Carboxy-terminal truncated rhuIFN-gamma with a substitution of Glnl33 or Serl32 to leucine leads to higher biological activity than in the wild type. Eur. J. Biochem. 202, 1133-1140.
89. Holmes, E. W., Russell, P. M., Kinzler, G. J., Reckard, C. G., Flanigan, R. C, Thompson, K. D., and Bermes, E. W. J. (1992). Oxidative tryptophane metabolism in renal allograft recipients: Increased kynurenine synthesis is associated with inflammation and OKT3 therapy. Cytokine 4, 205-213.
90. Saito, K., Markey, S. P., and Heyes, M. P. (1991). Chronic effects of γ-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57B16 mice. Brain Res 546, 151-154.
91. Burke, F., Knowles, R. G., East, N., and Balkwill, F. R. (1995). The role of indoleamine 2,3-dioxygenase in the anti-tumour activity of human interferon-gamma in vivo. Int. J. Cancer 60, 115-122.
92. Cassatella, M. A., Bazzoni, F., Flynn, R. M., Dusi, S., Trinchieri, G., and Rossi, F. (1990). Molecular basis of interferon-γ and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components. J. Biol. Chem. 265, 20241-20246.
93. Werner, E. R., Werner-Felmayer, G., and Wachter, H. (1993). Tetrahydrobiopterin and cytokines. Proc. Soc. Exp. Biol. Med. 203, 1-12.
94. Moncada, S., and Higgs, A. (1993). Mechanisms of disease: The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329, 2002-2012.
95. Snyder, S. H. (1993). Nitric oxide: first in a new class of neurotransmitters? Science 257, 494-496.
96. Kamijo, R., Shapiro, D., Le, J., Huang, S., Aguet, M., and Vilcek, J. (1993). Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc. Natl. Acad. Sci. USA 90, 6626-6630.
97. Stamler, J. S., Singel, D. J., and Loscalzo, J. (1993). Biochemistry of nitric oxide and its redox froms. Science 258, 1898-1902.
98. Weinberg, E. D. (1993). The iron-withholding defense system. ASM News 59,559-562.
99. Dijkmans, R., and Billiau, A. (1991). Interferon-γ/lipopolysaccharide-treated mouse embryonic fibroblasts are killed by a glycolysis/L-arginine-dependent process accompanied by depression of mitochondrial respiration. Eur. J. Biochem. 202, 151-159.
100. Drapier, J.-C., and Hibbs, J. B. (1988). Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Immunol. 140, 2829-2838.
101. Henry, Y., Lepoivre, M., Drapier, J.-C, Ducrocq, C., Boucher, J.-L., and Guissani, A. (1993). EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 7, 1124-1134.
102. Green, S. J., Nacy, C. A., and Meltzer, M. S. (1991). Cytokine-induced synthesis of nitrogen oxides in macrophages: A protective host response to Leishmania and other intracellular pathogens. J. Leukocyte Biol. 50, 93-103.
103. Rojas, A., Padron, J., Caveda, L., Palacios, M., and Moncada, S. (1993). Role of nitric oxide pathway in the protection against lethal endotoxemia afforded by low doses of lipopolysaccharide. Biochem. Biophys. Res. Commun. 191, 441-446.
104. Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J., and Lane, T. E. (1993). Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151, 2132-2
105. Southern, C., Schulster, D., and Green, I. C. (1990). Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-a via an L-arginine-dependent nitric oxide generating mechanism. FEBS. Lett. 276, 42-44.
106. Karupiah, G., Xie, Q., Buller, R. M. L., Nathan, C., Duarte, C., and MacMicking, J. D. (1993). Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261, 1445-1448.
107. Harris, N., Buller, R. M. L., and Karupiah, G. (1995). Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69, 910-915.
108. Taub, D. D., Lloyd, A. R., Conlon, K., Wang, J. M., Ortaldo, J. R., Harada, A., Matsushima, K., Kelvin, J., and Oppenheim, J. J. (1993). Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177,1809.
109. Lafuse, W. P., Brown, D., Castle, L., and Zwilling, B. S. (1995). Cloning and characterization of a novel cDNA that is IFN-gamma-induced in mouse peritoneal macrophages and encodes a putative GTP-binding protein. J. Leukocyte Biol. 57, 477-483.
110. Gilly, M., and Wall, R. (1992). The IRG-47 gene is IFN-γ induced in B cells and encodes a protein with GTP-binding motifs. J. Immunol. 148, 3275-3281.
111. Cheng, Y. S.-E., Patterson, C. E., and Staeheli, P. (1991). Interferon-induced guanylatebinding proteins lack an N(T)KXD consensus motif and bind GMP in addition to GDP and GTP. Mol. Cell. Biol. 11, 4717-4725.
112. Wynn, T. A., Nicolet, C. M., and Paulnock, D. M. (1991). Identification and characterization of a new gene family induced during macrophage activation. J. Immunol. 147, 4384-4392.
113. Symington, F. W. (1989). Lymphotoxin tumor necrosis factor, and gamma interferon are cytostatic for normal human keratinocytes. J. Invest. Dermatol. 92, 798-805.
114. Saunders, N. A., and Jetten, A. M. (1994). Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon gamma. Antagonism by retinoic acid and transforming growth factor β 1. J. Biol. Chem. 269, 2016-2022.
115. Wu, A. J., Kurrasch, R. H., Katz, J., Fox, P. C, Baum, B. J., and Atkinson, J. C. (1994). Effect of tumor necrosis factor-a and interferon-gamma on the growth of a human salivary gland cell line. J. Cell. Physiol. 161, 217-226.
116. Steiniger, B., Falk, P., and Van der Meide, P. (1988). Interferon-γ in vivo. Induction and loss of Class II MHC antigens and immature myelomonocytic cells in rat organs. Eur. J. Immunol. 18, 661-669.
117. Pujol-Borrell, R., Todd, I., Doshi, M., Botazzo, G. F., Sutton, D., Gray, D., Adolf, G. R., and Feldman, M. (1987). HLA Class II induction in human islet cells by interferon-γ plus tumor necrosis factor or lymphotoxin. Nature 326, 304-306.
118. Petroni, K., Shen, L., and Guyre, P. M. (1988). Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-γ and glucocorticoids. J. Immunol. 140, 3467-3472.
119. Guyre, P. M., Morganelli, P. M., and Miller, R. (1983). Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J. Clin. Invest. 72
120. Loughlin, A. J., Woodroofe, M. N., and Cuzner, M. L. (1992). Regulation of Fc receptor and major histocompatibility complex antigen expression on isolated rate microglia by tumour necrosis factor, interleukin-1 and lipopolysaccharide: Effects on interferon-gamma induced activation. Immunology, 75, 170-175.
121. Kontny, U., Kurane, I., and Ennis, F. (1988). Gamma interferon augments Fcγ receptor-mediated dengue virus infection of human monocytic cells. J. Virol. 62,3928-3933.
122. Naray Fejes-Toth, A., and Guyre, P. M. (1984). Recombinant human immune interferon induces increased IgE receptor expression on the human monocyte cell line U-9 3 7. J. Immunol. 133, 1914-1919.
123. Pancre, V., Joseph, M., Capron, A., Wietzerbin, J., Kusnierz, J.-P., Vorng, H., and Auriault, C. (1988). Recombinant human interferon-γ induces increased IgE receptor expression on human platelets. Eur. J. Immunol. 18, 829-832.
124. Dustin, M. L., Singer, K. H., Tuck, D. T., and Springer, T. A. (1988). Adhesion of T lymphoblasts to epidermal keartinocytes is regulated by interferon γ and is mediated by intercellular adhesion molecule 1 (ICAM-1). J. Exp. Med. 167, 1323-1340.
125. Freedman, A. S., Freeman, G. J., Rhynhart, K., and Nadler, L. M. (1991). Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol. 137, 429-437.
126. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., and Allison, J. P. (1992). CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356, 607-609.
127. Marth, C., Fuith, L. C., Bock, G., Daxenbichler, G., and Dapunt, O. (1989). Modulation of ovarian carcinoma tumor marker CA-125 by gamma interferon. Cancer Res. 49, 6538-6542.
128. Greiner, J. W., Guadagni, F., Hand, P. H., Pestka, S., Noguchi, P., and Fisher, P. B. (1990). Augmentation of tumor antigen expression by recombinant human interferons: Enhanced targeting of monoclonal antibodies to carcinomas. Cancer Treatment Res. 51, 413-432.
129. Leon, J. A., Mesa, T. R., Gutierrez, M. C., Estabrook, A., Greiner, J. W., Schlom, J., and Fisher, P. B. (1989). Increased surface expression and shedding of tumor associated antigens by human interferons or phorbol ester tumor promoters. Anticancer Res. 9, 1639-1647.
130. Wand-Wurttenberger, A., Schoel, B., Ivanyi, J., and Kaufmann, S. H. E. (1991). Surface expression by mononuclear phagocytes of an epitope shared with mycobacterial heat shock protein 60. Eur. J. Immunol. 21, 1089-1092.
131. Munn, D. H., Beall, A. C., Song, D., Wrenn, R. W., and Throckmorton, D. C. (1995). Activation-induced apoptosis in human macrophages: Developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon gamma. J. Exp. Med. 181, 127-136.
132. Mosser, D. M., and Handman, E. (1992). Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes. J. Leukocyte Biol. 52, 369-376.
133. Frasca, D., Adorini, L., Landolfo, S., and Dona, G. (1988). Enhancement of suppressor T cell activity by injection of anti-IFN-γ monoclonal antibody. J. Immunol. 140,4103-4107.
134. Ishikura, H., Jayaraman, S., Kuchroo, V., Diamond, B., Saito, S., and Dorf, M. E. (1989). Functional analysis of cloned macrophage hybridomas. J. Immunol. 143, 414-419.
135. Noma, T., and Dorf, M. E. (1985). Modulation of suppressor T cell induction with γ-interferon, J. Immunol. 135, 3655-3660.
136. Luster, A. D., Unkeless, J. C, and Ravetch, J. V. (1985). γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315, 672.
137. Hamilton, T. A., Bredon, N., Ohmori, Y., and Tannenbaum, C. S. (1989). IFN-γ and IFN-β independently stimulate the expression of lipopolysaccharide-inducible genes in murine peritoneal macrophages. J. Immunol. 142, 2325-2331.
138. Ohmori, Y., and Hamilton, T. A. (1994). IFN-gamma selectively inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages. J. Immunol. 153, 2204-2212.
139. Gusella, G. L., Musso, T., Bosco, M. C., Espinoza-Delgado, I., Matsushima, K., and Varesio, L. (1993). IL-2 up-regulates but IFN-y suppresses IL-8 expression in human monocytes. J. Immunol. 151, 2725-2732.
140. Heda, G. D., Mardente, S., Weiner, L., and Schmaier, A. H. (1990). Interferon gamma increases in vitro and in vivo expression of C1 inhibitor. Blood 75, 2401-2407.
141. Lotz, M., and Zuraw, B. L. (1987). Interferon-γ is a major regulator of C1-inhibitor synthesis by human blood monocytes. J. Immunol. 139, 3382-3387.
142. Grabbe, S., Bruvers, S., Beissert, S., and Granstein, R. D. (1994). Interferon-gamma inhibits tumor antigen presentation by epidermal antigen-presenting cells. J. Leukocyte Biol. 55, 695-701.
143. Simon, J. C, Cruz, P. D., Bergstresser, P. R., Davis, L. S., and Tigelaar, R. E. (1991). Phorbol myristate acetate-activated keratinocytes stimulate proliferation of resting peripheral blood mononuclear lymphocytes via a MHC-independent, but protein kinase C- and intercellular adhesion molecule-1-dependent mechanism. J. Immunol. 146, 476-484.
144. LaSalle, J. M., and Hafler, D. A. (1994). T cell anergy. FASEB J. 8, 601-608.
145. Huynh, H. K., and Dorovini-Zis, K. (1993). Effects of interferon-γ on primary cultures of human brain microvessel endothelial cells. Am. J. Pathol. 142, 1265-1278.
146. Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. E., and Springer, T. A. (1993). Tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). Induction by IL-la and interferon-y. J. Immunol. 137, 245-254.
147. McCarron, R. M., Wang, L., Racke, M. K., McFarlin, D. E., and Spatz, M. (1993). Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol. 43, 23-30.
148. Yu, C. L., Haskard, D. O., Cavender, D., Johnson, A., and Ziff, M. (1985). Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp. Immunol. 62, 554-560.
149. Male, D., Rahman, J., Linke, A., Zhao, W., and Hickey, W. (1995). An interferon-inducible molecular on brain endothelium which controls lymphocyte adhesion mediated by integrins. Immunology 84, 453-460.
150. Arenzana-Seisdedos, F., Virelizier, J. L., and Fiers, W. (1985). Interferons as macrophage activating factors. III. Preferential effects of interferon-γ on the interleukin-1 secretory potential of fresh or aged human monocytes. J. Immunol. 134, 2444-2448.
151. Haq, A. U., Rinehart, J. J., and Maca, R. D. (1985). The effect of gamma interferon on IL-1 secretion of in vitro differentiated human macrophages. J. Leukocyte Biol. 38, 735-746.
152. Miossec, P., and Ziff, M. (1986). Immune interferon enhances the production of interleukin 1 by human endothelial cells stimulated with lipopolysaccharide. J. Immunol. 137, 2848-2852.
153. Johnson, W. J., Breton, J., Newman-Tarr, T., Connor, J. R., Meunier, P. C, and Dalton, B. J. (1990). Interleukin-1 release by rat synovial cells is dependent on sequential treatment with γ-interferon and lipopolysaccharide. Arthritis Rheum. 33,261-267.
154. Marfaing-Koka, A., Devergne, O., Gorgone, G., Portier, A., Schall, T. J., Galanaud, P., and Emilie, D. (1995). Regulation of the production of the RANTES chemokine by endothelial cells: Synergistic induction by IFN-gamma plus TNF-α and inhibition by IL-4 and IL-13. J. Immunol. 154, 1870-1878.
155. Aggarwal, B. B., Eessalu, T. E., and Hass, P. E. (1985). Characterization of receptors for human tumor necrosis factor and their regulation by γ-interferon. Nature 318, 665-667.
156. Ruggiero, V., Tavernier, J., Fiers, W., and Baglioni, C. (1986). Induction of the synthesis of tumor necrosis factor receptors by interferon-y. J. Biol. Chem. 136, 2445-2450.
157. Tsujimoto, M., and Vilcek, J. (1986). Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-y. J. Biol. Chem. 261, 5384-5388.
158. Drapier, J.-C., and Wietzerbin, J. (1991). IFN-γ reduces specific binding of tumor necrosis factor on murine macrophages. J. Immunol. 146, 1198-1203.
159. Paul, W. (1991). Interleukin-4: A prototypic immunoregulatory lymphokine. Blood 77, 1859-1870.
160. Plum, J., De Smedt, M., Billiau, A., and Heremans, H. (1991). IFN-c reverses IL-4 inhibition of fetal thymus growth in organ culture. J. Immunol. 147, 50-54.
161. Gaspari, A. A., Jenkins, M. K., and Katz, S. I. (1988). Class II MHC-bearingkeratinoytes induce antigen-specific unresponsiveness in hapten-specific Thl clones. J. Immunol. 141, 2216-2220.
162. Gautam, S., Tebo, J. M., and Hamilton, T. A. (1992). IL-4 suppresses cytokine gene expression induced by IFN-y and/or IL-2 in murine peritoneal macrophages. J. Immunol. 148, 1725-1730.
163. Belosevic, M., Davis, C. E., Meltzer, M. S., and Nacy, C. A. (1988). Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. J. Immunol. 141, 890-896.
164. Lohoff, M., Marsig, E., and Rollinghof, M. (1990). Murine IL-4 antagonizes the protective effects of IFN on virus-mediated lysis of murine L929 fibroblast cells. J. Immunol. 144, 960-963.
165. Lamer, A. C, Petricoin, E. F., Nakagawa, Y., and Finbloom, D. S. (1993). IL-4 attenuates the transcriptional activation of both IFN-α- and IFN-γ-induced cellular gene expression in monocytes and monocytic cell lines. J. Immunol. 150, 1944-1950.
166. Pene, J., Rousset, F., Briere, F., Chretien, I., Palliard, X., Banchereau, J., Spits, H., and De Vries, J. E. (1988). IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-γ. J. Immunol. 141, 1218-1224.
167. Pene, J., Rousset, F., Briere, F., Chretien, I., Bonnefoy, J.-Y., Spits, H., Yokota, T., Arai, N., Arai, K.-I., Banchereau, J., and De Vries, J. E. (1988). IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons γ and α and prostaglandin E2. Proc. Natl. Acad. Sci. USA 85, 6880-6884.
168. Peleman, R., Wu, J., Fargeas, C., and Delespesse, G. (1989). Recombinant interleukin 4 suppresses the production of interferon gamma by the human mononuclear cells. J. Exp. Med. 170, 175
169. Vercelli, D., Jabara, H. H., Lauener, R. P., and Geha, R. S. (1990). IL-4 inhibits the synthesis of IFN-γ and induces the synthesis of IgE in human mixed lymphocyte cultures. J. Immunol. 144, 570-573.
170. Wagner, F., Fischer, N., Lersch, C., Hart, R., and Dancygier, H. (1989). Interleukin 4 inhibits interleukin 2-induced production of its functional antagonist, interferon gamma. Immunol. Lett. 21, 237-242.
171. Deng, W., Ohmori, Y., and Hamilton, T. A. (1994). Mechanisms of IL-4-mediated suppression of IP-10 gene expression in murine macrophages. J. Immunol. 153,2130-2136.
172. Fertsch, D., Schoenberg, D. R., Germain, R. N., Tou, J. Y., and Vogel, S. N. (1987). Induction of macophage la antigen expression by rIFN-gamma and down-regulation by IFN-alpha/beta and dexamethasone are mediated by changes in steady-state levels of la mRNA. J. Immunol. 139, 244-249.
173. Ling, P. D., Warren, M. K., and Vogel, S.N. (1985). Antagonistic effect of interferonα/β on the interferon-γ-induced expression of la antigen in murine macrophages. J. Immunol. 135, 1857-
174. Barna, B. P., Chou, S. M., Jacobs, B., Yen-Lieberman, B., and Ransohoff, R. M. (1989). Interferon-β impairs induction of HLA-DR antigen expression in cultured adult human a strocytes. J. Neuroimmunol. 23, 45-53.
175. Ransohoff, R. M., Devajyothi, C., Estes, M. L., Babcock, G., Rudick, R. A., Frohman, E. M., and Barna, B. P. (1991). Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line. J. Neuroimmunol. 33, 103-112.
176. Chantry, D., Turner, M., Abney, A., and Feldman, M. (1989). Modulation of cytokine production by transforming growth factor β. J. Immunol. 142, 4295-4300.
177. Espevik, T., Figari, I. S., Shalaby, M. R., Lewis, G. D., Shepard, H. M., and Palladino, M. S. J. (1987). Inhibition of cytokine production by cyclosporin A and transforming growth factor. J. Exp. Med. 166, 571-576.
178. Czarniecki, C. W., Chiu, H. H., Wong, G. H. W., McCabe, S. M., and Palladino, M. A. (1988). Transforming growth factor β modulates the expression of Class II histocompatibility antigens on human cells. J. Immunol. 140, 4217-4223.
179. Ding, A., Nathan, C. F., Graycar, J., Derynck, R., Stuehr, D. J., and Srimal, S. (1990). Macrophage deactivating factor and transforming growth factors-β1, -02, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J. Immunol. 145, 940-944.
180. Varga, J., Olsen, A., Herhal, J., Constantine, G., Rosenbloom, J., and Jiminez, S. A. (1990). Interferon-γ reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-β in normal human fibroblasts. Eur. J. Clin. Invest. 20, 487-493.
181. Moore, K. W., O'Garra, A., De Waal Malefyt, R., Vieira, P., and Mosmann, T. R. (1993). Interleukin-10. Annu. Rev. Immunol. 11, 165-190.
182. Wanidworanun, C., and Strober, W. (1993). Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J. Immunol. 151, 6853-6861.
183. Gazinelli, R., Oswald, I. P., James, S. L., and Sher, A. (1992). IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J. Immunol. 148, 1792-1796.
184. Florquin, S., Amraoui, Z., Abramowicz, D., and Goldman, M. (1994). Systemic release and protective role of IL-10 in staphylococcal entertoxin B-induced shock in mice. J. Immunol. 153, 2618-
185. Chomarat, P., Rissoan, M.-C, Banchereau, J., and Miossec, P. (1993). Interferon gamma inhibits interleukin 10 production by monocytes. J. Exp. Med. 177, 523-527.
186. Zurawski, G., and De Vries, J. (1994). Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15, 19-26.
187. Doherty, T. M., Kastelein, R., Menon, S., Andrade, S., and Coffman, R. L. (1993). Modulation of murine macrophage function by IL-13. J. Immunol. 151, 7151-7160.
188. Zimmer, T., and Jones, P. P. (1990). Combined effects of tumor necrosis factor-a, prostaglandin E2, and corticosterone on induced la expression on murine macrophages. J Immunol. 145, 1167.
189. Watanabe, Y., and Jacob, C. O. (1991). Regulation of MHC Class II antigen expression. Opposing effects of tumor necrosis factor-α on IFN-γ-induced HLA-DR and la expression depends on the maturation and differentiation stage of the cell. J. Immunol. 146, 899.
190. Beaman, M. H., Hunter, C. A., and Remington, J. S. (1994). Enhancement of intracellular replication of Toxoplasma gondii by IL-6: Interactions with IFN-gamma and TNF-α. J. Immunol. 153, 4583-4587.
191. Landolfo, S., Gariglio, M., Gribaudo, G., Jemma, C., Giovarelli, M., and Cavallo, G. (1988). Interferon-γ is not an antiviral, but a growth-promoting factor for T lymphocytes. Eur. J. Immunol. 18, 503-509.
192. Fernandez-Botran, R., Sanders, V. M., Mosmann, T. R., and Vitetta, E. S. (1988). Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J. Exp. Med. 168, 543-558.
193. Gajewsld, T. F., and Fitch, F. W. (1988). Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Thl murine helper T lymphocyte clones. J. Immunol. 140, 4252.
194. Wynn, T. A., Jankovic, D., Hieny, S., Zioncheck, K., Jardieu, P., Cheever, A. W., and Sher, A. (1995). IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-γ. J. Immunol. 154, 3999-4009.
195. Pernis, A., Gupta, Gollob, K. J., Garfein, E., Coffman, R. L., Schindler, C., and Rothman, P. (1995). Lack of interferon γ receptor β chain and the prevention of interferon y signalling in TH1 cells. Science 269, 245-247.
196. Liu, Y., and Janeway, C. A. J. (1990). Interferon y plays a critical role in induced cell death of effector T cell: A possible third mechanism of self-tolerance. J. Exp. Med. 172, 1735-1739.
197. Novelli, F., Di Pierro, F., Di Celle, P. F., Bertini, S., Affaticati, P., Garotta, G., and Forni, G. (1994). Environmental signals influencing expression of the IFN- gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis. J. Immunol. 152, 496-504.
198. Matthys, P., Froyen, G., Huang, S., Sobis, H., Van Damme, J., Aguet, M., and Billiau. A. (1995). Interferon-y receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis: Protective role of endogenous nitric oxide. J. Immunol. 155, 3823-3829.
199. Siegel, J. P. (1988). Effects on interferon-y on the activation of human T lymphocytes. Cell. Immunol. 111, 461-472.
200. Landolfo, S., Cofano, F., Giovarelli, M., Prat, M., Cavallo, G., and Forni, G. (1985). Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo. Science 229, 176-179.
201. Simon, M. M., Hochgeschwender, U., Brugger, U., and Landolfo, S. (1986). Monoclonal antibodies to interferon γ inhibit interleukin 2-dependent induction of growth and maturation in lectin/antigen-reactive cytolytic T lymphocyte precursors. J. Immunol. 136, 2755-2762.
202. Bucy, P., Hanto, D. W., Berens, E., and Schreiber, R. D. (1988). Lack of an obligate role for IFN-γ in the primary in vitro mixed lymphocyte response. J. Immunol. 140, 1148-1152.
203. Maraskowsky, E., Chen, W.-F., and Shortman, K. (1989). IL-2 and IFN-γ are two necessary mymphokines in the development of cytolytic T cells. J. Immunol. 143,1210-1214.
204. Sidman, C. L., Marshall, J. D., Schulz, L. D., Gray, P. W., and Johnson, H. M. (1984). γ-Interferon is one of several direct B cell-maturing lymphokines. Nature 309, 801-803.
205. Abed, N. A., Chace, J. H., Fleming, A. L., and Cowdery, J. S. (1994). Interferon-γ regulation of B lymphocyte differentiation: Activation of B cells is a prerequisite for IFN-γ-mediated inhibition of B cell differentiation. Cell Immunol. 153, 356-366.
206. Abed, N. S., Chace, J. H., and Cowdery, J. S. (1994). T cell-independent and T cell-dependent B cell activation increases IFN-gammaR expression and renders B cells sensitive to IFN-gamma-mediated inhibition. J. Immunol. 153, 3369-3377.
207. Garvy, B. A., and Riley, R. L. (1994). IFN-gamma abrogates IL-7-dependent proliferation in pre-B cells, coinciding with onset of apoptosis. Immunology 81, 381-388.
208. Grawunder, U., Melchers, F., and Rolink, A. (1993). Interferon-γ arrests proliferation and causes apoptosis in stromal cell/interleukin-7-dependent normal murine pre-B cell lines and clones in vitro, but does not induce differentiation to surface immunoglobulin-positive B cells. Eur. J. Immunol. 23, 544-551.
209. Trubiani, O., Bosco, D., and Di Primio, R. (1994). Interferon-gamma (IFN-gamma) induces programmed cell death in differentiated human leukemic B cell lines. Exp. CellRes. 215, 23-27.
210. Buschle, M., Campana, D., Carding, S. R., Richard, C., Hoffbrand, A. V., and Brenner, M. K. (1993), Interferon y inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J. Exp. Med. 177, 213-218.
211. White-Helman, S., and Wallace, J. H. (1989). Differential regulation of the immune response to SRBC by monoclonal antibodies to interferon-γ. Proc. Soc. Exp. Biol. Med. 191, 55-59.
212. Brunswick, M., and Lake, P. (1985). Obligatory role of gamma interferon in T-cell replacing factor-dependent, antigen-specific murine B cell responses. J. Exp. Med. 161, 953-971.
213. Kawano, Y., Noma, T., and Yata, J. (1994). Regulation of human IgG subclass production by cytokines: IFN-gamma and IL-6 act antagonistically in the induction of human IgGl but additively in the induction of IgG2. J. Immunol. 153, 4948-4958.
214. Kitani, A., and Strober, W. (1993). Regulation of Cγ subclass germ-line transcripts in human peripheral blood B cells. J. Immunol. 151, 3478-3488.
215. Nakagawa, T., Hirano, T., Nakagawa, N., Yooshizaki, K., and Kishimoto, T. (1985). Effect of recombinant IL-2 and γ-IFN on proliferation and differentiation of human B cells. J. Immunol. 134, 959-966.
216. Finkelman, F. D., Katona, I. M., Mosmann, T. R., and Coffman, R. L. (1988). IFN-y regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140, 1022-
217. Snapper, C. M., Peschel, C., and Paul, W. E. (1993). IFN-γ stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140,2121-2127.
218. Graham, M. B., Dalton, D. K., Giltinan, D., Braciale, V. L., Stewart,T. A., and Braciale, T. J. (1993). Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J. Exp. Med. 178, 1725-1732.
219. Dobber, R., Tielemans, M., and Nagelkerken, L. (1995). The in vivo effects of neutralizing antibodies against IFN-gamma, IL-4, or IL-10 on the humoral immune response in young and aged mice. Cell Immunol. 160, 185-192.
220. Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J., Zinkernagel, R. M, and Aguet, M. (1993). Immune response in mice that lack the interferon-gamma receptor. Science 259, 1742-1745.
221. Bogen, S. A., Fogelman, I., and Abbas, A. K. (1993). Analysis of IL-2, IL-4, and IFNgamma-producing cells in situ during immune responses to protein antigens. J. Immunol. 150, 4197-4205
222. King, C. L., Gallin, J. I., Malech, H. L., and Abramson, S. L. (1989). Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon y. Proc. Natl. Acad. Sci. USA 86, 10085-10089.
223. Rousset, F., Robert, J., Andary, M., Bonnin, J. P., Souillet, G., Chretien, I., Briere, F., Pene, J., and De Vries, J. (1991). Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J. Allergy Clin. Immunol. 87,58-69.
224. King, C. L., Low, C. C., and Nutman, T. B. (1993). IgE production in human helminth infection: Reciprocal interrelationship between IL-4 and I FN - γ. J. Immunol. 150, 1873-1880.
225. Li, J. T. C, Yunginger, J. W., Jaffe, H. S., Nelson, D. R., and Gleich, G. J. (1990). Lack of suppression of IgE production by recombinant interferon gamma: A controlled trial in patients with allergic rhinitis. J. Allergy Clin. Immunol. 85, 934-940.
226. Lack, G., Renz, H., Saloga, J., Bradley, K. L., Loader, J., Leung, D. Y. M., Larsen, G., and Gelfand, E. W. (1994). Nebulized but not parenteral IFN-γ decreases IgE production and normalizes airways function in a murine model of allergen sensitization. J. Immunol. 152
227. Reinhold, U., Wehrman, W., Kukel, S., and Kreysel, H. W. (1990). Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin. Exp. Immunol. 79, 374-380.
228. Hanifin, J. M., Schneider, L. C, Leung, D. Y. M., Ellis, C. N., Jaffe, H. S., Izu, A. E., Bucalo, L. R., Hirabayashi, S. E., Tofte, S. J., Cantu-Gonzales, G., Milgrom, H., Boguniewicz, M., and Cooper, K. D. (1993). Recombinant interferon gamma therapy for atopic dermatitis. J. Am. Acad. Dermatol. 28, 189-197.
229. Horneff, G., Dirksen, U., and Wahn, V. (1994). Interferon-gamma for treatment of severe atopic eczema in two children. Clin. Invest. 72, 400-403.
230. Wall, D. A., Hamberg, S. D., Burakoff, S. J., Reynolds, D. S., Abbas, A. K., and Ferrara, L. M. (1988). Immunodeficiency in garft-versus-host disease. I. Mechanism of immune suppression. J. Immunol. 140, 2970-2976.
231. Huchet, R., Bruley-Rosset, M., Mathiot, C., Grandjon, D., and Halle-Pannenko, O. (1993). Involvement of IFN-gamma and transforming growth factor-β in graft-vs-host reaction-associated immunosuppression. J. Immunol. 150, 2517-2524.
232. Metzger, Z., Hoffeld, J. T., and Oppenheim, J. J. (1980). Macrophage-mediated suppression. I. evidence for participation of both hydrogen peroxide and prostaglandin in suppression of murine lymphocyte proliferation. J. Immunol. 124, 983-988.
233. Boraschi, D., Censini, S., and Tagliabue, A. (1984). Interferon-γ reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production. J. Immunol. 133, 764-768.
234. Albina, J. E., Abate, J. A., and Henry, W. L. J. (1991). Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-γ in the induction of nitric oxide-synthesizing pathway. J. Immunol. 147, 144-148.
235. Mills, C. D. (1991). Molecular basis of suppressor macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146, 2719-2723.
236. Twardzik, D. R., Mikovits, J. A., Ranchalis, J. E., Purchio, A. F., Ellingswaorth, L., and Ruscetti, F. W. (1990). c-Interferon-induced activation of latent transforming growth-factor-β by human monocytes. Ann. NY Acad. Sci. 593, 276-284.
237. Adams, R. B., Planchon, S. M., and Roche, J. K. (1993). IFN-γ modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J. Immunol. 150, 2353-2363.
238. Flohr, T., Buwitt, U., Bonnekoh, B., Decker, T., and Böttger, E. C. (1992). Interferon-γ regulates expression of a novel keratin class I gene. Eur. J. Immunol. 22, 975-979.
239. Vogel, U., Denecke, B., Troyanovsky, S. M., Leube, R. E., and Böttger, E. C. (1995). Transcriptional activation of psoriasis-associated cytokeratin K17 by interferon-gamma-Analysis of gamma-interferon activation sites. Eur. J. Biochem. 227,143-149.
240. Amento, E. P., Bhan, A. K., McCullagh, K. G., and Krane, S. M. (1985). Influence of gamma interferon on synovial fibroblast-like cells: la induction and inhibition of collagen synthesis. J. Clin. Invest. 76, 836-848.
241. Jiminez, S. A., Freundlich, B., and Rosenbloom, J. (1984). Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J. Clin. Invest. 74, 1112-1116.
242. Goldring, M. B., Sandell, L. J., Stephenson, M. L., and Krane, S. M. (1986). Immune interferon suppresses levels of procollagen mRNA and type III collagen synthesis in cultured human articular and costal chondrocytes. J. Biol. Chem. 261, 9049-9056.
243. Rosenbloom, J., Feldman, G., Freundlich, B., and Jiminez, S. A. (1984). Transcriptional control of human diploid fibroblast collagen synthesis by gamma interferon. Biochem. Biophys. Res. Commun. 123, 365-372.
244. Granstein, R. D., Murphy, G. F., Margolis, R. J., Byrne, M. H., and Amento, E. P. (1987). Gamma-interferon inhibits collagen synthesis in vivo in the mouse. J. Clin. Invest. 79, 1254-1258.
245. Granstein, R. D., Deak, M.-R., Jacques, S. L., Margolis, R. J., Flotte, T. J., Whitaker, D., Long, F. H., and Amento, E. P. (1989). The systemic administration of gamma interferon inhibits collagen synthesis and acute inflammation in a murine skin wounding model. J. Invest. Dermatol. 93, 18-27.
246. Giri, S. N., Hyde, D. M., and Marafino, B. J. J. (1986). Amelioration effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice. Biochem. Med. Metabol. Biol. 36, 194-197.
247. Patton, J. S., Shepard, H. M., Wilking, H., Lewis, G., Aggarwal, B. B., Eessalu, T. E., Gavin, L. A., and Grunfeld, C. (1986). Interferons and tumor necrosis factor have similar catabolic effects on 3T3-L1 cells. Proc. Natl. Acad. Sci. USA 83, 8313-8317.
248. Doerrler, W., Feingold, K. R., and Grunfeld, C. (1994). Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 6, 478-484.
249. Feingold, K. R., Doerrler, W., Dinarello, C. A., Fiers, W., and Grunfeld, C. (1992). Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferon is blocked by inhibition of prostaglandin synthesis. Endocrinology 130, 10-16.
250. Sobel, R. A., Mitchell, M. E., and Fondren, G. (1990). Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am. J. Pathol. 136, 1309-1316.
251. Traugott, U., and Lebon, P. (1988). Multiple sclerosis: Involvement of interferons in lesion pathogenesis. Ann. Neurol. 24, 243-251.
252. Satoh, J., Kastrukoff, L. F., and Kim, S. U. (1991). Cytokine-induced expression of intercellular adhesion molecule-1 (ICAM-1) in cultured human oligodendrocytes and astrocytes. J. Neuropathol. Exp. Neurol. 50, 215-226.
253. Pulver, M., Carrel, S., Mach, J. P., and de Tribolet, N. (1987). Cultured human fetal astrocytes can be induced by interferon-y to express HLA-DR. J. Neuroimmunol. 14, 123-133.
254. Mauerhoff, T., Pujol-Borrell, R., Mirakian, R., and Botazzo, G.F. (1988). Differential expression and regulation of major histocompatibility complex (MHC) products in neural and glial cells of the human fetal brain. J. Neuroimmunol. 18, 271-289.
255. Frohman, E. M., Frohman, T. C, and Dustin, M. L. (1989). The induction of intercellular adhesion molecule-1 (ICAM-1) expression on human fetal astrocytes by interferon-y, tumor necrosis factor α, lymphotoxin, and interleukin-1: Relevance to intracerebral antigen presentation. J. Neuroimmunol. 23, 117-124.
256. Yong, V. W., Yong, F. P., Ruijs, T. C. G., Antel, J. P., and Kim, S. U. (1991). Expression and modulation of HLA-DR on cultured human adult astrocytes. J. Neuropathol. Exp. Neurol. 50, 16-28.
257. Aloisi, F., Borsellino, G., and Samoggia, P. (1992). Astrocyte cultures from human embryonic brain: Characterization and modulation of surface molecules by inflammatory cytokines. J. Neurosci. Res. 32, 494-506.
258. Satoh, J., Paty, D. W., and Kim, S. U. (1995). Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes. Neurology 45, 367-373.
259. S. Panek, R. B., Lee, Y.-J., Lindstrom-Itoh, Y., Ting, J. P.-Y., and Benveniste, E. N. (1994). Characterization of astrocyte nuclear proteins involved in IFN-γ and TNF-α mediated class II MHC gene expression. J. Immunol. 153, 4555.
260. Panek, R. B., and Benveniste, E. N. (1995). Class II MHC gene expression in microglia. Regulation by the cytokines IFN-γ, TNF-α and TGF-β. J. Immunol. 154, 2846-2854.
261. Li, Y., Atashi, J., Hayes, C., Reap, E., Hunt, S., III, and Popko, B. (1995). Morphological and molecular response of the MOCH-1 oligodendrocyte cell line to serum and interferon-gamma: Possible implications for demyelinating disorders. J. Neurosci. Res. 40, 189-198.
262. Mamus, S. W., Beck Schroeder, S., and Zanjani, E. D. (1985). Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes. J. Clin. Invest. 75, 1496-1503.
263. Broxmeyer, H. E., Lu, L., Platzer, E., Feit, C., Juliano, L., and Rubin, B. Y. (1983). Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J. Immunol. 131, 1300-1305.
264. Sarris, A. H., Broxmeyer, H. E., Wirthmueller, U., Karasawas, N., Cooper, S., Lu, L., Krueger, J., and Ravetch, J. V. (1993). Human interferon-inducible protein 10: Expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors. J. Exp. Med. 178, 1127-1132.
265. Shiohara, M., Koike, K., and Nakahata, T. (1993). Synergism of interferon-gamma and stem cell factor on the development of murine hematopoietic progenitors in serum-free culture. Blood 81, 1435-1441.
266. Caux, C., Moreau, I., Saeland, S., and Banchereau, J. (1992). Interferon-gamma enhances factor-dependent myeloid proliferation of human CD34+ hematopoietic progenitor cells. Blood 79, 2628-2635.
267. Means, R. T. J., and Krantz, S. B. (1991). Inhibition of human erythroid colony-forming units by interferon-gamma can be corrected by recombinant human erythropoietin. Blood 78, 2564-2567.
268. Wang, C. Q., Udupa, K. B., and Lipschitz, D. A. (1995). Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. J. Cell. Physiol. 162, 134-138.
269. Nishikawa, T., Yamashita, S., Namba, H., Usa, T., Tominaga, T., Kimura, H., Izumi, M., and Nagataki, S. (1993). Interferon-y inhibition of human thyrotropin receptor gene expression. J. Clin. Endocrinol. Metab. 77, 1084-1089.
270. Kraiem, Z., Sobel, E., Sadeh, O., Kinarty, A., and Lahat, N. (1990). Effects of γ-interferon on DR antigen expression, growth, 3,5,3'-triiodothyronine secretion, iodide uptake and cyclic adenosine 3',5'-monophosphate accumulation in cultured human thyroid cells. J. Clin. Endocrinol. Metab. 71, 817-824.
271. Kung, A. W. C, and Lau, K. S. (1990). Interferon-γ inhibits thyrotropin-induced thyroglobulin gene transcription in cultured human thyrocytes. J. Clin. Endocrinol. Metab. 70, 1512-1517.
272. Asakawa, H., Hanafusa, T., Kobayashi, T., Takai, S.-I., Kono, N., and Tarui, S. (1992). Interferon-γ reduces the thyroid peroxidase content of cultured human thyrocytes and inhibits its increase induced by thyrotropin. J. Clin. Endocrinol. Metab. 74,1331-1335.
273. Tang, K.-T., Braverman, L. E., and DeVito, W. J. (1995). Tumor necrosis factor-α and interferon-gamma modulate gene expression of type I 5'-deiodinase, thyroid peroxidase, and thyroglobulin in FRTL-5 rat thyroid cells. Endocrinology 136, 881-888.
274. Vankelecom, H., Carmeliet, P., Heremans, H., Van Damme, J., Dijkmans, R., Billiau, A., and Denef, C. (1990). Interferon-γ inhibits stimulated adrenocorticotropin, prolactin, and growth hormone secretion in normal rat anterior pituitary cell cultures. Endocrinology 126, 2919-2926.
275. Vankelecom, H., Andries, M., Billiau, A., and Denef, C. (1992). Evidence that folliculostellate cells mediate the inhibitory effect of interferon-γ on hormone secretion in rat anterior pituitary cell cultures. Endocrinology 130, 3537-3546.
276. Allaerts, W., Carmeliet, P., and Denef, C. (1990). New perspectives in the function of pituitary folliculo-stellate cells. Mol. Cell. Endocrinol. 71, 73-81.
277. Vankelecom, H., Carmeliet, P., Van Damme, J., Billiau, A., and Denef, C. (1989). Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histotypic cell aggregate culture system. Neuroendocrinology 49, 102-106.
278. Vankelecom, H., and Billiau, A. (1992). Interferon-γ in neuroimmunology and endocrinology. Adv. Neuroimmunol. 2, 139-161.
279. Ottenhof, T. H. M., and Mutis, T. (1995). Role of cytotoxic cells in the protective immunity against and immunopathology of intracellular infections. Eur. J. Clin. Invest. 25, 371-377.
280. Belosevic, M., Finbloom, D. S., Van der Meide, P. H., Slayter, M. V., and Nacy, C. A. (1989). Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates natural resistance of C3H/He Nmiceto infection with Leishmania major. J. Immunol. 143, 266-274.
281. Scott, P. (1991). IFN-gamma modulates the early development of Thl and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147, 3149-3155.
282. Sileghem, M., Hamers, R., and De Baetselier, P. (1987). Experimental Trypanosoma brucei infections selectively suppress both interleukin 2 production and interleukin 2 receptor expression. Eur. J. Immunol. 17, 1417-1421.
283. Billiau, A., Heremans, H., Vandekerckhove, F., and Dillen, C. (1987). Anti-interferon-c antibody protects mice against the generalized Shwartzman reaction. Eur. J. Immunol. 17, 1851-1854.
284. Billiau, A., and Vandekerckhove, F. (1991). Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur. J. Clin. Invest. 21, 559-573.
285. Heremans, H., Van Damme, J., Dillen, C., Dijkmans, R., and Billiau, A. (1990). Interferon-c, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J. Exp. Med. 171, 1853-1869.
286. Fennie, E. H., Lie, Y. S., Low, M.-A. L., Gribling, P., and Anderson, K. P. (1988). Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-γ treatment. Antiviral Res. 10, 27-39.
287. Haagmans, B. L., Van der Meide, P. H., Stals, F. S., Van den Eertwegh, A. J. M., Claassen, E., Bruggeman, C. A., Horzinek, M. C, and Schijns, V. E. C. J. (1994). Suppression of rat cytomegalovirus replication by antibodies against gamma interferon. J. Virol. 68, 2305
288. Leist, T. P., Eppler, M., and Zinkemagel, R. M. (1989). Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice, J. Virol. 63, 2813-2819.
289. Heise, M. T., and Virgin, H. W. (1995). The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69, 904-909.
290. Lucchiari, M. A., Modolell, M., Eichmann, K., and Pereira, C. A. (1992), In vivo depletion of interferon-gamma leads to susceptibility of A/J mice to mouse hepatitis virus 3 infection. Immunobiology 185, 475-482.
291. Stanton, G. J., Jordan, C., Hart, A., Heard, H., Langford, M. P., and Baron, S. (1995). Nondetectable levels of interferon gamma is acritical host defense during the first day of herpes simplex virus infection. Microbial Pathogenesis 3, 179-183.
292. Alcami, A., and Smith, G. L. (1995). Cytokine receptors encoded by poxviruses: A lesson in cytokine biology. Immunol. Today 16, 474-478.
293. Biswas, P., Poli, G., Kintner, A. L., Justement, J. S., Stanley, S. K., Maury, W. J., Bressler, P., Orenstein, J. M., and Fauci, A. S. (1992). Interferon γ modulates the expression of huan immunodeficiency virus in persistently infected promonocytic cells by redirecting the production of virions to intracytoplasmic vacuoles. J. Exp. Med. 176, 739-750.
294. Koyanagi, Y., O'Brien, W. A., Zhao, J. Q., Golde, Gasson, J. C, and Chen, I. S. Y. (1988). Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 241, 1673-1675.
295. Jarpe, M. A., Hayes, M. P., Russell, J. K., Johnson, H. M., and Russell, S. W. (1989). Causal association of interferon-γ with tumor regression. J. Interferon Res. 9,239-244.
296. Prat, M., Bretti, S., Amedeo, M., Landolfo, S., and Comoglio, P. M. (1987). Monoclonal antibodies against murine IFN-y abrogate in vivo tumor immunity against RSV-induced cytotoxic T lymphocyte differentiation. J. Immunol. 138, 4530-4533.
297. Gansbacher, B., Bannerji, R., Daniels, B., Zier, K., Cronin, K., and Gilboa, E. (1990). Retroviral vector-mediated gamma-interferon gene transfer to tumor cells generates potent and long-lasting antitumor immunity. Cancer Res. 50, 7820-7825.
298. Watanabe, Y., Kuribayashi, K., Miyatake, S., Nishihara, E., Nakayama, E., Taniyama, T., and Sakata, T. A. (1989). Endogenous expression of mouse interferon γ cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity and augmented anti-tumor immunity. Proc. Natl. Acad. Sci. USA 86, 9456-9460.
299. + T cell-mediated tumor rejection and development of antitumor immunity: Comparative studies with IFN-gamma-producing TS/A cells. J. Immunol. 153, 4604-4615.
300. Matthys, P., Heremans, H., Opdenakker, G., and Billiau, A. (1991). Anti-interferon-c-antibody treatment, growth of Lewis lung rumors in mice and tumor-associated cachexia. Eur. J. Cancer 27, 182-187.
301. Ramani, P., and Balkwill, F. R. (1987). Enhanced metastasis of a mouse carcinoma after in vitro treatment with interferon-γ. Int. J. Cancer 40, 830-834.
302. Billiau, A., and Matthys, P. (1992). Interferon-γ, more of a cachectin than tumor necrosis factor. Cytokine 4, 259-263.
303. Langstein, H. N., Doherty, G. M, Fraker, D. L., Buresh, C. M., and Norton, J. A. (1991). The roles of γ-interferon and tumor necrosis factor α in an experimental rat model of cancer cachexia. Cancer Res. 51, 2302-2306.
304. Matthys, P., Dijkmans, R., Proost, P., Van Damme, J., Heremans, H., Sobis, H., and Billiau, A. (1991). Severe cachexia in mice inoculated with interferon-y-producing tumor cells. Int. J. Cancer 49, 77-82.
305. Diamantstein, T., Eckert, R., Volk, H.-D., and Kupier-Weglinski, J.-W. (1988). Reversal by interferon-y of inhibition of delayed-type hypersensitivity induction by anti-CD4 or antiinterleukin 2 receptor (CD25) monoclonal antibodies. Evidence for the physiological role of the CD4+TH1+ subset in mice. Eur. J. Immunol. 18, 2101-2103.
306. Fong, T. A., and Mosmann, T. R. (1989). The role of IFN-γ in delayed-type hypersensitivity mediated by Thl clones. J. Immunol. 143, 2887-2893.
307. Issekutz, T. B., Stoltz, J. M., and Van der Meide, P. (1988). Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-γ. J. Immunol. 140, 2889-2893.
308. Geiger, K., and Sarvetnick, N. (1994). Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID. J. Immunol. 153
309. Barker, J. N., Goodlad, J. R., Ross, E. L., Yu, C. C, Groves, R. W., and MacDonald, D. M. (1993). Increased epidermal cell proliferation in human skin in vivo following local administration of interferon-gamma. Am. J. Pathol. 142, 1091-1097.
310. Nathan, C. F., Kaplan, G., Levis, W. R., Nusrat, A., Witmer, M. D., Sherwin, S. A., Job, C. K., Path, F. R. C, Horowitz, C. R., Steinman, R. M., and Cohn, Z. A. (1986). Local and systemic effects of intradermal recombinant interferon-γ in patients with lepromatous leprosy. N. Engl. J. Med. 315, 6-15.
311. Taborski, U., Freitag, W., Heremans, H., and Knop, J. (1986). Inhibitory effects of interferon-y on the suppressor cell circuit in contact sensitivity. Immunobiology 171, 329-338.
312. Skoglund, C., Scheynius, A., Holmdahl, R., and Van der Meide, P. H. (1988). Enhancement of DTH reactions and inhibition of the expression of class II transplantation antigens by in vivo treatment with antibodies against y-interferon. Clin. Exp. Immunol. 71, 428-430.
313. Skoglund, C., and Scheynius, A. (1990). Effects of interferon-γ treatment on the cutaneous DTH reaction in rats. Arch. Dermatol. Res. 282, 318-324.
314. Sarvetnick, N., Shizuru, J., Liggitt, L., McInryre, B., Gregory, A., Parslow, T., and Stewart, T. (1990). Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature 346, 844-847.
315. Lee, M.-S., Von Herrath, M., Reiser, H., Oldstone, M. B. A., and Sarvetnick, N. (1995). Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. J. Clin. Invest. 95, 486-492.
316. Kawakami, Y., Kuzuya, N., Watanabe, T., Uchiyama, Y., and Yamashita, K. (1990). Induction of experimental thyroiditis in mice by recombinant interferon y administration. Acta Endocrinol. 122, 41-48.
317. Tang, H., Mignon-Godefroy, K., Meroni, P. L., Garotta, G., Charreire, J., and Nicoletti, F. (1993). The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): Prevention of disease and decrease of EAT-specific T cells. Eur. J. Immunol. 23, 275-278.
318. Campbell, I. L., Kay, T. W. H., Oxbrow, L., and Harrison, L. C. (1991). Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87, 739-742.
319. Hartung, H.-P., Schäfer, B., Van der Meide, P. H., Fierz, W., Heininger, K., and Toyka, K. V. (1990). The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neurol. 27, 247-257.
320. Strigard, K., Holmdahl, R., Van der Meide, P. H., Klareskog, L., and Olsson, T. (1989). In vivo treatment of rats with monoclonal antibodies against gamma interferon: Effects on experimental allergic neuritis. Acta Neurol. Scand. 80, 201-207.
321. Billiau, A., Heremans, H., Vandekerckhove, F., Dijkmans, R., Sobis, H., Meulepas, E., and Carton, H. (1988). Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J. Immunol. 140, 1506-1510.
322. Duong, T. T., St. Louis, J., Gilbert, J. J., Finkelman, F. D., and Strejan, G. H. (1992). Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 36, 105-115.
323. Caspi, R. R., Chan, C.-C, Grubbs, B. G., Silver, P. B., Wiggert, B., Parsa, C. F., Bahmanyar, S., Billiau, A., and Heremans, H. (1994). Endogenous systemic IFNgamma has a protective role against ocular autoimmunity in mice. J. Immunol. 152, 890-899.
324. Voorthuis, J. A. C, Uitdehaag, B. M. J., De Groot, C. J. A., Goede, P. H., Van der Meide, P. H., and Dijkstra, C. D. (1990). Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in rats. Clin. Exp. Immunol. 81, 183-188.
325. Duong, T. T., Finkelman, F. D., Singh, B., and Strejan, G. H. (1994). Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53, 101-107.
326. Mustafa, M., Diener, P., Hojeberg, B., Van der Meide, P., and Olsson, T. (1991). T cell immunity and interferon-y secretion during experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 31, 165-177.
327. McDonald, A. H., and Swanborg, R. H. (1988). Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis. J. Immunol. 140, 1132-1138.
328. Cross, A. H., Misko, T. P., Lin, R. F., Hickey, W. F., Trotter J. L., and Tilton, R. G. (1994). Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93, 2684-2690.
329. Mauritz, N. J. Holmdal, R, Jonsson, R., Van der Meide, P. H., Scheynius, A., and Klareskog, L. (1988). Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum. 31, 1297-1304.
330. Nakajima, H., Takamori, H., Hiyama, T., and Tsukuda, W. (1990). The effect of treatment with interferon-gamma on type II collegen-induced arthritis. Clin. Exp. Immunol. 81, 441-445.
331. Wahl, S. M., Allen, J. B. Ohura, K., Chenoweth, D. W., and Hand, A. R. (1991). IFN-y inhibits inflammatory cell recruitment and the evolution of bacterial cell wall-induced arthritis. J. Immunol. 146, 95-100
332. Matthys, P., Heremans, H., Dillen, C., and Billiau, A. (1989). Effects of interferon-y and anti-interferon-y antibodies on experimental arthritis in mice. J. Interferon Res. 9S, 130.[Abstract]
333. Alvaro-Gracia, J. M., Zvaifler, N. J., and Firestein, G. A. (1990). Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis actor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony stimulating factor production by rheumatoid arthritis synoviocytes. J. Clin. Invest. 86, 1790-1798.
334. Nakajima, H., Hiyama, T., Tsulcuda, W., Warabi, H., Uchida, S., and Hirose, S. (1990). Effects of interferon gamma on cultured synovial cell from patients with rheumatoid arthritis: Inhibition of cell growth, prostaglandin E2, and collagenase release. Ann. Rheum. Dis. 49, 512-516.
335. Ruschen, S., Leram, G., and Warnatz, H. (1989). Spontaneous and LPS-stimulated production of intracellular IL-1β by synovial macrophages in rheumatoid arthritis is inhibited by IFN-γ. Clin. Exp. Immunol. 76, 246-251.
336. Andrews, H. J., Bunning, R. A. D., Dinarello, C. A., and Russell, R. G. G. (1989). Modulation of human chondrocyte metabolism by recombinant human interferon-gamma: In vitro effects on basal and IL-1-stimulated proteinase production, cartilage degradation and DNA synthesis. Biochim. Biophys. Acta 1012, 128-134.
337. Bunning, R. A. D., and Russell, G. G. (1989). The effect of tumor necrosis factor-α and γ-interferon on the resorption of human articular cartilage and on the production of prostaglandin E and of caseinase activity by human articular chondrocytes. Arthritis Rheum. 32, 780-784.
338. Gowen, M., and Mundy, G. R. (1986). Action of recombinant interleukin 1, interleukin 2 and interferon-y on bone resorption in vitro. J. Immunol. 136, 2478-2482.
339. Takahashi, N., Mundy, G., and Roodman, G. D. (1986). Recombinant human interferon-y inhibits formation of human osteoclast-like cells. J. Immunol. 137, 3544-3549.
340. Campbell, I. L., Oxbrow, L., Koulmanda, M., and Harrison, L. C. (1988). IFN-γ induces islet MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J Immunol. 140, 1111-1116.
341. Debraye-Sachs, M., Carnaud, C., Boitard, C., Cohen, H., Gresser, I., Bedossa, P., and Bach, J. (1991). Prevention of diabetes in NOD mice treated with antibody to murine IFNγ. J. Autoimmunity 4, 237-248.
342. Kay, T. W. H., Campbell, I. L., Oxbrow, L., and Harrison, L. C. (1991). Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-y antibody. Diabetologia 34, 779-785.
343. Campbell, I. L., Oxbrow, L., and Harrison, L. C. (1991). Reduction in insulitis following administration of IFN-γ and TNF-α in the NOD mouse. J. Autoimmunity 4, 249-262.
344. Gu, D., and Sarvetnick, N. (1993). Epithelial cell proliferation and islet neogenesis in IFN-γ transgenic mice. Development 118, 33-46.
345. Wogensen, L., Molony, L., Gu, D., Krahl, T., Zhu, S., and Sarvetnick, N. (1994). Postnatal anti-interferon-γ treatment prevents pancreatic inflammation in transgenic mice with β-cell expression of interferon-γ. J. Interferon Res. 14, 111-116.
346. Lee, M.-S., and Sarvetnick, N. (1994). Induction of vascular addressins and adhesion molecules in the pancreas of IFN-gamma transgenic mice. J. Immunol. 152, 4597-4603.
347. Yamada, K., Otabe, S., Inada, C., Takane, N., and Nonaka, K. (1993). Nitric oxide and nitric oxide synthase mRNA induction in mouse islet cells by inteferon-γ plus tumor necrosis factor-α. Biochem. Biophys. Res. Commun. 197, 22-27.
348. Rosenberg, A. S., Finbloom, D. S., Maniero, T. G., Van der Meide, P. H., and Singer, A. (1990). Specific prolongation of MHC Class II disparate skin allografts by in vivo administration of anti-IFN-y monoclonal antibody. J. Immunol. 144, 4648-4650.
349. Gorczynski, R. M. (1995). Regulation of IFN-gamma and IL-10 synthesis in vivo, as well as continuous antigen exposure, is associated with tolerance to murine skin allografts. Cell. Immunol. 160, 224-231.
350. Brok, H. P. M., Heidt, P. J., Van der Meide, P. H., Zurcher, C., and Vossen, J. (1993). Interferon-γ prevents graft versus host disease after allogeneic bone marrow transplantation in mice. J. Immunol. 151, 6451-6459.
351. Cleveland, M. C, Annable, C. R., and Klimpel, G. R. (1988). In vivo and in vitro production of IFN-β and IFN-y during graft vs host disease. J. Immunol. 141, 3349-3356.
352. Garside, P., Reid, S., Steel, M., and Mowat, A. M. (1994). Differential cytokine production associated with distinct phases of murine graft-versus-host reaction. Immunology 82, 211-214.
353. Mowat, A. M. I. (1989). Antibodies to IFN-y prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology 68, 18-23.
354. Donckier, V., Abramowiez, D., Bruyns, C., Florquin, S., Vanderhaeghen, M.-L., Amraoui, Z., Dubois, C., Vandenabeele, P., and Goldman, M. (1994). IFN-gamma prevents TH2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice. J. Immunol. 153, 2361-2368.
355. Heremans, H., Dijkmans, R., Sobis, H., Vandekerckhove, F., and Billiau, A. (1987). Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide. J. Immunol. 138, 4175-4179.
356. Matthys, P., Mitera, T., Heremans, H., Van Damme, J., and Billiau, A. (1995). Anti-IFN-γ and anti-IL-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia and cytokine release in D-galactosamine-sensitized and unsensitized mice. Infect. Immun. 63, 1158-1164.
357. Miethke, T., Wahl, C., Heeg, K., Echtenacher, B., Krammer, P. H., and Wagner, H. (1992). T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor. J. Exp. Med. 175, 91-98.
358. Ferran, C., Dy, M., Sheehan, K., Schreiber, R. Grau, G., Bluestone, J., Bach, J., and Chatenoud, L. (1991). Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-γ, interleukin-3 and interleukin-6 release after triggering of the CD3/T cell receptor activation pathway. Eur. J. Immunol. 21, 2349-2353.
359. Matthys, P., Dillen, C., Proost, P., Heremans, H., Van Damme, J., and Balliau, A. (1993). Modification of the anti-CD3-induced cytokine release syndrome by anti-interferon-y or anti-interleukin-6 antibody treatment: Protective effects and biphasic changes in blood cytokine levels. Eur. J. Immunol. 23, 2209-2216.
360. Bach, E. A., Szabo, S. J., Dighe, A. S., Ashkenazi, A., Aguet, M., Murphy, K. M., and Schreiber, R. D. (1995). Ligand-induced autoregulation of IFN-γ receptor β-chain expression in T helper cell subsets. Science 270, 1215-1218.
361. Sakatsume, M., Igarashi, K., Winestock, K. D., Garotta, G., Lamer, A. C., and Finbloom, D. S. (1995). The Jak kinases differentially associate with the α and β (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors. J. Biol. Chem. 270,17528-17534.
362. Guyer, N. B., Sevens, C. W., Wong, P., Feghali, C. A., and Wright, T. M. (1995). IFN-gamma induces a p91/Statlα-related transcription factor with distinct activation and binding properties, J. Immunol. 155, 3472-3480.
363. Reith, W., Steimle, V., and Mach, B. (1995). Molecular defects in the bare lymphocyte syndrome and regulation of MHC Class II genes. Immunol. Today 16, 539-546.
364. Chang, C. H., Pontes, J. D., Peterlin, M., and Flavell, R. A. (1994). Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180, 1367-1374.
365. Steimle, V., Siegrist, C. A., Mottet, A., Lisowska-Grospierre, B., and Mach, B. (1994). Regulation of MHC class II expression by interferon gamma mediated by transactivator CIITA. Science 265, 106-109.
366. Carson, W. E., Ross, M. E. Baiocchi, R. A., Marica, M. J., Bolani, N., Grabstein, K., and Caligiuri, M. A. (1995). Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J. Clin Invest. 96, 2578-2582.
367. Cardillo, F., Voltarelli, J. C, Reed, S. G., and Silva, J. S. (1996) Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: Role of NK cells Infect. Immun. 64, 128-134.
368. Flynn, J. L., Goldstein, M. M., Triebold, K. J., Sypek, J., Wolf, S., and Bloom, B. R. (1995). IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155, 2515-2524.
369. Zhou, P., Sieve, M. C, Bennett, J., Kwon-Chung, K. J., Tewari, R. P., Gazzinelli, R. T., Sher, A., and Seder, R. A. (1995). IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J. Immunol. 155,785-795.
370. Nakane, A., Okamoto, M., Asano, M., Kohanawa, M., and Minagawa, T. (1995). Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect. Immun. 63, 1165-1172.
371. Zhao, Y.-X., and Tarkowski, A. (1995). Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. J. Immunol. 155, 5736-5742.
372. Candolfl, E., Hunter, C. A., and Remington, J. S. (1995). Roles of gamma interferon and other cytokines in suppression of the spleen cell response to concanavalin A and toxoplasm antigen during acute toxoplasmosis. Infect. Immun. 63, 751-756.
373. Tomioka, H., Sato, K., Maw, W. W., and Saito, H. (1995). The role of tumor necrosis factor, interferon-γ transforming growth factor β, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection. J. Leukoe. Biol. 58, 704-712.
374. Ferber, I. A. Brocke, S., Taylor-Edwards, C., Ridgway, W. Dinisco, C., Steinman, L., Dalton, D., and Fathman, C. G. (1996). Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5-
375. Boissier, M.-C, Chiocchia, G., Bessis, N., Hajnal, J,, Garotta, G., Nicoletti, F., and Fournier, C. (1995). Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur. J. Immunol. 25, 1184-1190.